528 related articles for article (PubMed ID: 8652081)
1. Clinical toxicity of cytokines used as haemopoietic growth factors.
Vial T; Descotes J
Drug Saf; 1995 Dec; 13(6):371-406. PubMed ID: 8652081
[TBL] [Abstract][Full Text] [Related]
2. Immune-mediated side-effects of cytokines in humans.
Vial T; Descotes J
Toxicology; 1995 Dec; 105(1):31-57. PubMed ID: 8638283
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.
Ballestrero A; Ferrando F; Garuti A; Basta P; Gonella R; Stura P; Mela GS; Sessarego M; Gobbi M; Patrone F
J Clin Oncol; 1999 Apr; 17(4):1296. PubMed ID: 10561192
[TBL] [Abstract][Full Text] [Related]
5. [GM-CSF and G-CSF: cytokines in clinical application].
Ruef C; Coleman DL
Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
[TBL] [Abstract][Full Text] [Related]
6. Secondary cytokines interact in sequence with interleukin-1alpha (IL-1alpha) with or without macrophage colony-stimulating factor (M-CSF) to further accelerate granulopoietic recovery in myelosuppressed animals.
Kovacs CJ; Evans MJ; Daly BM; Thomas-Patterson D; Johnke RM; Powell DS
J Interferon Cytokine Res; 1997 Aug; 17(8):453-60. PubMed ID: 9282825
[TBL] [Abstract][Full Text] [Related]
7. Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.
Schiller JH; Hank JA; Khorsand M; Storer B; Borchert A; Huseby-Moore K; Burns D; Wesly O; Albertini MR; Wilding G; Sondel PM
Clin Cancer Res; 1996 Feb; 2(2):319-30. PubMed ID: 9816175
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic effects of cytokines: clinical and preclinical studies.
Bukowski RM; Olencki T; McLain D; Finke JH
Stem Cells; 1994; 12 Suppl 1():129-40; discussion 140-1. PubMed ID: 7696957
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
[TBL] [Abstract][Full Text] [Related]
11. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
13. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
[TBL] [Abstract][Full Text] [Related]
14. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
Gazzola MV; Collins NH; Tafuri A; Keever CA
Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
[TBL] [Abstract][Full Text] [Related]
15. Secretion of GM-CSF and M-CSF by human renal cell carcinomas of different histologic types.
Gerharz CD; Reinecke P; Schneider EM; Schmitz M; Gabbert HE
Urology; 2001 Nov; 58(5):821-7. PubMed ID: 11711375
[TBL] [Abstract][Full Text] [Related]
16. c-kit ligand augments granulocyte-macrophage colony growth from patients with 5q- syndrome.
Rosenfeld CS; Nemunaitis J; Sherer CR; Zeigler ZR; Shadduck RK
Stem Cells; 1993 Nov; 11(6):562-7. PubMed ID: 7509225
[TBL] [Abstract][Full Text] [Related]
17. Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-hodgkin's lymphoma undergoing cytoreductive chemotherapy.
Reisbach G; Kamp T; Welzl G; Geiz C; Abedinpour Fariborz ; Lodri A; Kaboth W; Dörmer P; Nerl C
Br J Haematol; 1996 Mar; 92(4):907-12. PubMed ID: 8616084
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of hematopoietic growth factors.
Vose JM; Armitage JO
J Clin Oncol; 1995 Apr; 13(4):1023-35. PubMed ID: 7535842
[TBL] [Abstract][Full Text] [Related]
19. Potentiating effect of granulocyte-macrophage colony-stimulating factor on interleukin-1-induced thymocyte proliferation: evidence for an interleukin-2 and tumor necrosis factor-independent pathway.
Herbelin A; Machavoine F; Dy M
Lymphokine Res; 1990; 9(2):155-65. PubMed ID: 2187117
[TBL] [Abstract][Full Text] [Related]
20. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome.
Aggarwal A; Baker CS; Evans TW; Haslam PL
Eur Respir J; 2000 May; 15(5):895-901. PubMed ID: 10853855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
